Literature DB >> 6445100

In vitro generation of human mixed lymphocyte culture suppressor cells. I. Cellular characterization and specificity.

L Fuller, G Kyriakides, C Flaa, V Esquenazi, J Miller.   

Abstract

The mixed leukocyte culture (MLC) of peripheral blood lymphocytes (PBLs) from two prospective kidney transplant recipients and their respective donors, produced a primed cell population that functioned as suppressors. The primed cells suppressed the primary and secondary MLC when added as third components, without demonstrable cytotoxic cells. Suppressor cells were derived from the MLCs of related pairs that were genotyped to be: (1) serologically defined (SD) identical and lymphocyte-defined (LD) nonidentical, and (2) HLA (total MHC) identical. Primed cells derived from MLC of unrelated HLA nonidentical subjects also showed similar effects. Two general patterns of inhibition were observed: a marked specific suppression of the autologous responding cells and, to a lesser degree, nonspecific suppression. The T cell fraction derived from the primed suppressor population was suppressive, the cells with B cell characteristics were not suppressive. The suppressive effect of cells generated in MLC was serially monitored after kidney transplantation. The suppressive activity of the primed cells was absent in the early postoperative period (4 weeks), perhaps because of high dose immunosuppression, but later in the course suppression was evident again (2 to 5 months). Manipulation of this T suppressor cell population may prove to be of value in enhancing graft acceptance.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6445100     DOI: 10.1097/00007890-198001000-00012

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

1.  The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients.

Authors:  R Garcia-Morales; M Carreno; J Mathew; K Zucker; R Cirocco; G Ciancio; G Burke; D Roth; D Temple; A Rosen; L Fuller; V Esquenazi; T Karatzas; C Ricordi; A Tzakis; J Miller
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

2.  The effect of cimetidine on PBL from healthy donors and melanoma patients: augmentation of T cell responses to TCGF mitogens and alloantigens and of TCGF production.

Authors:  A Eisenthal; J Monselise; R Zinger; A Adler
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Long-term study of vascularized free-draining intraperitoneal pancreatic segmental allografts in beagle dogs.

Authors:  G K Kyriakides; A Rabinovitch; D Mintz; L Olson; F T Rapaport; J Miller
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.